M. Mahrous

发表

Erlotinib in patients with advanced non-small cell lung cancer in Middle Eastern population

A. Jazieh, Yosra Z. Ali, N. Sheblaq, 2018, Journal of Immunotherapy and Precision Oncology.

Primary Squamous Cell Carcinoma of the Breast is a Rare and Special Entity. A Case Report from Arab Region with Aggressive Behavior and follow up 25 Months

M. Mahrous, Tasabeeh Mohamed, Ghassan Al Sisi, 2018, Journal of Analytical Oncology.

The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer.

A. Shamseddine, S. Khatib, H. Kourie, 2022, Future oncology.

Histopathologic characterization of prostate diseases in Madinah, Saudi Arabia.

A. Hussainy, A. Alhujaily, A. Albasri, 2014, Asian Pacific journal of cancer prevention : APJCP.

Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia

Mohammed I. Alghamdi, K. Al-saleh, S. Bazarbashi, 2022, Journal of oncology.

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

K. Imrie, Hany R. Guirguis, R. Buckstein, 2012, British journal of haematology.

Saudi lung cancer management guidelines 2017

J. Ansari, A. Jazieh, W. Khalbuss, 2017, Annals of thoracic medicine.

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer.

J. Zekri, A. Rizvi, T. Darwish, 2015, Experimental oncology.

Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature

F. Elzein, M. Alsaeed, E. Murshid, 2021, Journal of Infection and Public Health.

Protracted Adjuvant Temozolomide in Glioblastoma Multiforme

D. Salem, A. Refae, M. Mahrous, 2015 .

Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.

S. Elsamany, J. Al-Maghrabi, J. Zekri, 2017, Genetics and molecular research : GMR.

Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium.

A. Jazieh, H. Al-Shamsi, E. Black, 2022, Cancer treatment and research communications.

Frequency and Clinical Impact of KRAS Mutations in Patients with Colorectal Cancer from the Middle East

J. Zekri, A. Al-Shehri, S. Karim, 2016 .

Consensus Recommendations for the Diagnosis, Biomarker Testing, and Clinical Management of Advanced or Metastatic Non-small Cell Lung Cancer With Mesenchymal-Epithelial Transition Exon 14 Skipping Mutations in the Middle East, Africa, and Russia

M. Meergans, S. Kılıçkap, M. Ouda, 2023, Cureus.

Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: Final results of a multicentric trial in Egypt

Amr Yehia Sakr, H. Elghazaly, H. Tawfik, 2008 .

Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia

S. Bazarbashi, F. Ibnshamsah, M. Mahrous, 2024, Journal of hepatocellular carcinoma.

Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study

S. Bazarbashi, M. Mahrous, M. Aseafan, 2024, JCO global oncology.